Publications by authors named "Lise Fenou"

Claim this Profile
R
Replication-Poison Treatment in BRCA1-Deficient Breast Cancer Causes MRE11 Over-Resection That Induces Single-Stranded DNA Accumulation and Mitotic Catastrophe.
Imene Tabet, Esin Orhan, Ermes Candiello, Lise Fenou, Carolina Velázquez

Cancer Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK inhibition results in pharmacologic BRCAness increasing sensitivity to olaparib in BRCA1-WT and olaparib resistant in Triple Negative Breast Cancer.
Esin Orhan, Carolina Velazquez, Imene Tabet, Lise Fenou, Geneviève Rodier

Cancer Lett· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer.
Pénélope Desroys du Roure, Laurie Lajoie, Aude Mallavialle, Lindsay B Alcaraz, Hanane Mansouri, Lise Fenou

J Immunother Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
-
-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib.
Carolina Velazquez, Esin Orhan, Imene Tabet, Lise Fenou, Béatrice Orsetti

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis